Bridgepoint has agreed to exit its investment in Vitamin Well, known for its premium functional beverages, welcoming Cinven as new lead investor.

Since partnering in 2016, Bridgepoint helped Vitamin Well in expanding internationally its activities and boost revenue twelvefold. Bridgepoint will maintain a significant minority stake, alongside Cinven, to support continued global growth.

The M&A/Corporate team involved in the sale was led by Cédric Bless and Imède EL MOUDDEN from our Luxembourg office.

For more information, please see the press release here.